Ejection Fraction, Peak Exercise Oxygen Consumption, Cardiothoracic Ratio, Ventricular Arrhythmias, and Plasma Norepinephrine as Determinants of Prognosis in Heart Failure

BackgroundRecognition of the complex pathophysiology of heart failure and its high mortality has emphasized the need for prognostic markers that can be used in clinical assessment as well as in the design of mortality trials. Data from the Department of Veterans Affairs Cooperative Vasodilator-Heart Failure Trials (V-HeFT I, 642 patients; V-HeFT II, 804 patients) were therefore examined to determine the influence of prerandomization measurements on subsequent mortality. Methods and ResultsPatients entered into these trials were men with cardiac dysfunction and reduced peak exercise capacity. Measurements included in this analysis were left ventricular ejection fraction (EF) measured by radionuclide angiography, peak bicycle exercise oxygen consumption (Vo2), cardiothoracic ratio (CTR) measured on a chest x-ray, ventricular arrhythmias assessed in a core laboratory by short-term Holter monitoring, plasma norepinephrine and plasma renin activity measured in a core laboratory only in V-HeFT II, and a variety of diagnostic and demographic data. The variables related only weakly to each other. EF, Vo2, and CTR were powerful independent predictors of all-cause mortality in both studies. Ventricular arrhythmia was a significant independent predictor in V-HeFT II but not in V-HeFT I. Plasma norepinephrine but not plasma renin activity measured in V-HeFT II also had independent prognostic value. Other variables did not exert an independent effect on mortality. ConclusionsOptimal assessment of the mortality risk in an individual or a group of individuals with heart failure uses measurement of EF, peak Vo2, CTR, plasma norepinephrine, and the presence of ventricular arrhythmias.

[1]  R M Whitlock,et al.  Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. , 1987, Circulation.

[2]  J. Cohn,et al.  Heart failure with normal ejection fraction. The V-HeFT study , 1990 .

[3]  J. Kjekshus Arrhythmias and mortality in congestive heart failure. , 1990, The American journal of cardiology.

[4]  J. Cohn,et al.  Current therapy of the failing heart. , 1988, Circulation.

[5]  B. Chance,et al.  Abnormal skeletal muscle bioenergetics during exercise in patients with heart failure: role of reduced muscle blood flow. , 1986, Circulation.

[6]  J. Cohn Prognostic factors in heart failure: Poverty amidst a wealth of variables , 1989 .

[7]  P. Poole‐Wilson,et al.  Symptoms limiting exercise in chronic heart failure. , 1986, British medical journal.

[8]  P. Dunselman,et al.  Value of New York Heart Association classification, radionuclide ventriculography, and cardiopulmonary exercise tests for selection of patients for congestive heart failure studies. , 1988, American Heart Journal.

[9]  G. Francis Development of arrhythmias in the patient with congestive heart failure: pathophysiology, prevalence and prognosis. , 1986, The American journal of cardiology.

[10]  B. Massie,et al.  Correlates and prognostic implication of exercise capacity in chronic congestive heart failure. , 1985, The American journal of cardiology.

[11]  M. Pike,et al.  Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. , 1977, British Journal of Cancer.

[12]  F. Tristani,et al.  Veterans Administration Cooperative Study on Vasodilator Therapy of Heart Failure: influence of prerandomization variables on the reduction of mortality by treatment with hydralazine and isosorbide dinitrate. , 1987, Circulation.

[13]  J. Cohn,et al.  Relative attenuation of sympathetic drive during exercise in patients with congestive heart failure. , 1985, Journal of the American College of Cardiology.

[14]  J. Cohn,et al.  Prognosis of congestive heart failure and predictors of mortality. , 1988, The American journal of cardiology.

[15]  M. Wilén,et al.  Relation of right ventricular ejection fraction to exercise capacity in chronic left ventricular failure. , 1984, The American journal of cardiology.

[16]  M. Weiner,et al.  Impaired skeletal muscle function in patients with congestive heart failure. Relationship to systemic exercise performance. , 1991, The Journal of clinical investigation.

[17]  J. Cohn,et al.  Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. , 1984, The New England journal of medicine.

[18]  F. Tristani,et al.  A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. , 1991, The New England journal of medicine.

[19]  R. Gourgon,et al.  Assessment of exercise tolerance in chronic congestive heart failure. , 1991, The American journal of cardiology.

[20]  S. Frostick,et al.  Skeletal muscle metabolism in patients with congestive heart failure: relation to clinical severity and blood flow. , 1987, Circulation.

[21]  J. Cohn,et al.  Predicting survival for an individual with congestive heart failure using the plasma norepinephrine concentration. , 1987, American heart journal.

[22]  J. Cohn,et al.  Heart failure: mechanisms of cardiac and vascular dysfunction and the rationale for pharmacologic intervention , 1990, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[23]  J. Cohn,et al.  Activity of the sympathetic nervous system and renin-angiotensin system assessed by plasma hormone levels and their relation to hemodynamic abnormalities in congestive heart failure. , 1982, The American journal of cardiology.

[24]  J. Cohn,et al.  Response of plasma norepinephrine and epinephrine to dynamic exercise in patients with congestive heart failure. , 1982, The American journal of cardiology.

[25]  W. Milnor,et al.  Arterial impedance as ventricular afterload. , 1975, Circulation research.

[26]  T. Levine,et al.  Lack of correlation between exercise capacity and indexes of resting left ventricular performance in heart failure. , 1981, The American journal of cardiology.

[27]  D.,et al.  Regression Models and Life-Tables , 2022 .

[28]  M. Wilén,et al.  Functional capacity of patients with chronic left ventricular failure. Relationship of bicycle exercise performance to clinical and hemodynamic characterization. , 1979, The American journal of medicine.